Goldenwell Biotech, Inc. (GWLL)
- Previous Close
0.0586 - Open
0.0586 - Bid --
- Ask --
- Day's Range
0.0586 - 0.0586 - 52 Week Range
0.0586 - 0.2950 - Volume
7,041 - Avg. Volume
0 - Market Cap (intraday)
5.801M - Beta (5Y Monthly) -0.57
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing five products, including JI MAIbovine cardiac vascular active peptide; cartilage peptide, a type II collagen peptide; and Double Proline AG 3D active collagen peptide, as well as Se Plus tablets and sugar master tablets. The company was incorporated in 2019 and is based in Twinsburg, Ohio.
www.goldenwellbiotech.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: GWLL
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: GWLL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: GWLL
Valuation Measures
Market Cap
5.80M
Enterprise Value
5.78M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.82k
Price/Book (mrq)
54.98
Enterprise Value/Revenue
2.47k
Enterprise Value/EBITDA
-49.45
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-30.67%
Return on Equity (ttm)
-81.65%
Revenue (ttm)
2.34k
Net Income Avi to Common (ttm)
-116.89k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
53.23k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-71.83k
Company Insights: GWLL
GWLL does not have Company Insights